Adrian Brady

27.0k total citations
46 papers, 1.0k citations indexed

About

Adrian Brady is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Adrian Brady has authored 46 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Cardiology and Cardiovascular Medicine, 12 papers in Surgery and 10 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Adrian Brady's work include Blood Pressure and Hypertension Studies (8 papers), Lipoproteins and Cardiovascular Health (7 papers) and Venous Thromboembolism Diagnosis and Management (7 papers). Adrian Brady is often cited by papers focused on Blood Pressure and Hypertension Studies (8 papers), Lipoproteins and Cardiovascular Health (7 papers) and Venous Thromboembolism Diagnosis and Management (7 papers). Adrian Brady collaborates with scholars based in United Kingdom, Georgia and United States. Adrian Brady's co-authors include Peter T. Donnan, Annie S. Anderson, Sally Wyke, Shaun Treweek, Petra Rauchhaus, Elisabeth Fenwick, Cindy M. Gray, Alan White, Eleanor Grieve and Nanette Mutrie and has published in prestigious journals such as The Lancet, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Adrian Brady

43 papers receiving 973 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adrian Brady United Kingdom 14 278 251 205 178 117 46 1.0k
Frank Verheyen Germany 16 374 1.3× 85 0.3× 140 0.7× 106 0.6× 70 0.6× 53 1.2k
Anne-Françoise Gaudin France 20 191 0.7× 131 0.5× 270 1.3× 77 0.4× 32 0.3× 67 1.5k
Orna Reges Israel 14 427 1.5× 97 0.4× 184 0.9× 91 0.5× 69 0.6× 53 837
Caroline Main United Kingdom 15 196 0.7× 182 0.7× 132 0.6× 173 1.0× 304 2.6× 24 1.2k
Pirjo Immonen‐Räihä Finland 23 707 2.5× 86 0.3× 108 0.5× 136 0.8× 113 1.0× 45 1.7k
Peggy Hamm United States 9 809 2.9× 180 0.7× 335 1.6× 270 1.5× 119 1.0× 12 1.6k
Emmanuel Sorbets France 15 419 1.5× 67 0.3× 156 0.8× 166 0.9× 30 0.3× 32 939
R F Gillum United States 17 461 1.7× 169 0.7× 226 1.1× 182 1.0× 85 0.7× 28 1.3k
Itziar Etxeandia‐Ikobaltzeta United States 18 131 0.5× 55 0.2× 157 0.8× 233 1.3× 45 0.4× 32 1.1k
Linda Schieb United States 20 596 2.1× 65 0.3× 86 0.4× 199 1.1× 53 0.5× 39 1.5k

Countries citing papers authored by Adrian Brady

Since Specialization
Citations

This map shows the geographic impact of Adrian Brady's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrian Brady with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrian Brady more than expected).

Fields of papers citing papers by Adrian Brady

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adrian Brady. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrian Brady. The network helps show where Adrian Brady may publish in the future.

Co-authorship network of co-authors of Adrian Brady

This figure shows the co-authorship network connecting the top 25 collaborators of Adrian Brady. A scholar is included among the top collaborators of Adrian Brady based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adrian Brady. Adrian Brady is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Edgar, B., Robert Pearson, Ram Kasthuri, et al.. (2022). The impact of renal artery stenting on therapeutic aims. Journal of Human Hypertension. 37(4). 265–272. 3 indexed citations
2.
Murray, Scott W., et al.. (2021). The “discordant doppelganger dilemma”: SGLT2i mimics therapeutic carbohydrate restriction - food choice first over pharma?. Journal of Human Hypertension. 35(8). 649–656. 9 indexed citations
3.
Unwin, David, et al.. (2019). Substantial and Sustained Improvements in Blood Pressure, Weight and Lipid Profiles from a Carbohydrate Restricted Diet: An Observational Study of Insulin Resistant Patients in Primary Care. International Journal of Environmental Research and Public Health. 16(15). 2680–2680. 54 indexed citations
4.
Vidal, Verónica, et al.. (2018). Anticoagulation in Patients with Ischaemic Heart Disease and Peripheral Arterial Disease: Clinical Implications of COMPASS Study. European Cardiology Review. 13(2). 115–115. 7 indexed citations
5.
Bohula, Erin A., David A. Morrow, Robert P. Giugliano, et al.. (2017). Atherothrombotic Risk Stratification and Ezetimibe for Secondary Prevention. Journal of the American College of Cardiology. 69(8). 911–921. 117 indexed citations
6.
Torbicki, Adam, Arnaud Perrier, Stavros Konstantinides, et al.. (2016). GUIDELINES ON THE DIAGNOSIS AND MANAGEMENT OF ACUTE PULMONARY EMBOLISM. SHILAP Revista de lepidopterología. 1 indexed citations
7.
8.
Brady, Adrian, et al.. (2013). Fulminant Idiopathic Intracranial Hypertension With Malignant Systemic Hypertension—A Case Report. Neuro-Ophthalmology. 37(3). 120–123. 9 indexed citations
9.
Gray, Christen M., Kate Hunt, Annie S. Anderson, Adrian Brady, & Peter T. Donnan. (2012). Football Fans in Training (FFIT): a pragmatic randomized controlled trial of a gender-sensitised weight loss and healthy living programme delivered to men aged 35-65 by Scottish Premier League (SPL) football clubs (protocol). The Lancet. 1 indexed citations
10.
Weir, Robin A.P., et al.. (2010). A cautionary tale--false-positive troponin I in pregnancy. QJM. 104(5). 439–440. 2 indexed citations
11.
Torbicki, Adam, Arnaud Perrier, Stavros Konstantinides, et al.. (2008). Guías de práctica clínica de la Sociedad Europea de Cardiología. Guías de práctica clínica sobre diagnóstico y manejo del tromboembolismo pulmonar agudo. Revista Española de Cardiología. 61(12). 1 indexed citations
12.
Weir, Robin A.P., John J.V. McMurray, Jacqueline Taylor, & Adrian Brady. (2006). Heart failure in older patients. ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam). 4 indexed citations
13.
Marshall, G., et al.. (2005). Should ail diabetic patients receive aspirin? Results from recent trials. 12(3). 120–125. 1 indexed citations
14.
Brady, Adrian, et al.. (2003). The cost-effectiveness of a new statin (rosuvastatin) in the UK NHS.. PubMed. 57(9). 792–800. 8 indexed citations
15.
Webster, John, et al.. (2003). The effects of KT3‐671, a new angiotensin II (AT 1) receptor blocker in mild to moderate hypertension. British Journal of Clinical Pharmacology. 56(5). 513–519. 5 indexed citations
16.
Brady, Adrian, et al.. (2001). Secondary prevention in 24 431 patients with coronary heart disease: survey in primary care. BMJ. 322(7300). 1463–1463. 64 indexed citations
17.
Brady, Adrian. (1995). Nitric oxide, myocardial failure and septic shock. International Journal of Cardiology. 50(3). 269–272. 13 indexed citations
18.
Brady, Adrian & P. A. Poole‐Wilson. (1993). Circulatory failure in septic shock. Nitric oxide: too much of a good thing?. Heart. 70(2). 103–105. 22 indexed citations
19.
Lopez, Anthony, Adrian Brady, & James E. Jackson. (1992). Case report: Therapeutic bronchial artery embolization in a case of Takayasu's arteritis. Clinical Radiology. 45(6). 415–417. 5 indexed citations
20.
Warren, J. B., Adrian Brady, & Graham W. Taylor. (1990). Vascular smooth muscle influences the release of endothelium-derived relaxing factor. Proceedings of the Royal Society B Biological Sciences. 241(1301). 127–131. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frank Verheyen Breakdown of academic impact, for papers by Anne-Françoise Gaudin Breakdown of academic impact, for papers by Orna Reges Breakdown of academic impact, for papers by Caroline Main Breakdown of academic impact, for papers by Pirjo Immonen‐Räihä Breakdown of academic impact, for papers by Peggy Hamm Breakdown of academic impact, for papers by Emmanuel Sorbets Breakdown of academic impact, for papers by R F Gillum Breakdown of academic impact, for papers by Itziar Etxeandia‐Ikobaltzeta Breakdown of academic impact, for papers by Linda Schieb
Rankless by CCL
2026